Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite cytoskeletal proteins are a diverse group of structural and regulatory molecules that form the dynamic framework essential for parasite survival, morphology, motility, host cell invasion, replication, and pathogenicity. These proteins include actin filaments, microtubules, intermediate filaments, molecular motors (such as myosins, dyneins, kinesins), and various associated or regulatory proteins. Many parasite-specific isoforms or novel cytoskeletal-associated proteins exist that are not found in hosts—these can be potential drug targets. Examples include paramyosin in helminths and apical complex proteins in Apicomplexans like Toxoplasma gondii. They are attractive targets for anti-parasitic drugs because they are often essential for viability and have unique sequences or structures compared to mammalian homologues. Disruption can impair key processes like motility or invasion without affecting host cells if specificity is achieved.
Disruption of cytoskeletal structure and function, inhibiting parasite motility, division, or invasion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite Cytoskeletal Protein.